Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 17/20 | 0.53 |
| ▸ | CHRNB4 | P30926 | 17/20 | 0.53 |
| ▸ | CHRNA3 | P32297 | 17/20 | 0.53 |
| ▸ | CHRNA4 | P43681 | 17/20 | 0.53 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11900414 | 1.00 | CHRNB2 (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11900415 | 1.00 | CHRNB2 (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11900448 | 1.00 | CHRNB2 (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11901730 | 1.00 | CHRNB2 (0.53) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11900384 | 0.88 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11900378 | 0.88 | CHRNB2 (0.46) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL1672225 | 0.83 | CHRNB2 (0.50) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL1673196 | 0.81 | CHRNB2 (0.50) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11900321 | 0.80 | HCRTR1 (0.48) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 | |
| SCHEMBL11900320 | 0.80 | HCRTR1 (0.48) | CHRNB2CHRNB4CHRNA3CHRNA4HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2491034-B1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2013-12-18 | — | — | EP | disclosed |
| EP-2491034-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | Janssen Pharmaceutica, N.V. (BE) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011050200-A1 | FUSED HETEROCYCLIC COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2011-04-28 | — | — | WO | disclosed |